Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction. Gestosis (late toxicosis of pregnant women) — pathological conditions of the second half of pregnancy, characterized by a triad of main symptoms: edema (hidden and visible), proteinuria, hypertension. In the third trimester, during physiological pregnancy of women and, especially when it is complicated by gestosis, there is a decrease in salivation, an increase in the viscosity and acidity of the oral fluid, which significantly increases the severity of the course of inflammatory periodontal diseases. We have developed a method for local treatment and prevention of gingivitis in women with pregnancy complicated by preeclampsia using a chewing phyto-substrate. Purpose: to assess changes in the physicochemical and biochemical parameters of the oral fluid during the local treatment of gingivitis using a chewing phyto-substrate in pregnant women with gestosis. Materials and methods: the examination of pregnant women was carried out in cooperation with obstetricians-gynecologists at the clinical base of the Department of Obstetrics and Gynecology No. 2 at the City Clinical Hospital No. 8, Ufa. Physicochemical (salivation rate, kinematic viscosity, pH) and biochemical parameters (calcium, magnesium, phosphorus, protein) of the oral fluid were determined before and after complex treatment of gingivitis with the inclusion of a chewing phyto-substrate in pregnant women with gestosis. Conclusion: in the third trimester during physiological pregnancy and, especially when it is complicated by gestosis, there is a decrease in salivation, an increase in the viscosity and acidity of the oral fluid. The use of chewing phytosubstrate plates in complex treatment, containing 0.1 g of dry extract of the collection (oak bark, licorice alder, birch buds, chamomile flowers, thyme herb) and 1.0 g of beeswax, increases the rate of salivation by 1.5 times, reduces the viscosity of the oral fluid by 1.3 times and its acidity, which indicates the effectiveness of the proposed method of local treatment of gingivitis in pregnant women with preeclampsia.
Introduction. Gestosis (late toxicosis of pregnant women) — pathological conditions of the second half of pregnancy, characterized by a triad of main symptoms: edema (hidden and visible), proteinuria, hypertension. In the third trimester, during physiological pregnancy of women and, especially when it is complicated by gestosis, there is a decrease in salivation, an increase in the viscosity and acidity of the oral fluid, which significantly increases the severity of the course of inflammatory periodontal diseases. We have developed a method for local treatment and prevention of gingivitis in women with pregnancy complicated by preeclampsia using a chewing phyto-substrate. Purpose: to assess changes in the physicochemical and biochemical parameters of the oral fluid during the local treatment of gingivitis using a chewing phyto-substrate in pregnant women with gestosis. Materials and methods: the examination of pregnant women was carried out in cooperation with obstetricians-gynecologists at the clinical base of the Department of Obstetrics and Gynecology No. 2 at the City Clinical Hospital No. 8, Ufa. Physicochemical (salivation rate, kinematic viscosity, pH) and biochemical parameters (calcium, magnesium, phosphorus, protein) of the oral fluid were determined before and after complex treatment of gingivitis with the inclusion of a chewing phyto-substrate in pregnant women with gestosis. Conclusion: in the third trimester during physiological pregnancy and, especially when it is complicated by gestosis, there is a decrease in salivation, an increase in the viscosity and acidity of the oral fluid. The use of chewing phytosubstrate plates in complex treatment, containing 0.1 g of dry extract of the collection (oak bark, licorice alder, birch buds, chamomile flowers, thyme herb) and 1.0 g of beeswax, increases the rate of salivation by 1.5 times, reduces the viscosity of the oral fluid by 1.3 times and its acidity, which indicates the effectiveness of the proposed method of local treatment of gingivitis in pregnant women with preeclampsia.
Introduction. Edema of pregnant women is a pathological condition in the second half of pregnancy, in which disorders of the functions of vital organs are noted and an exacerbation of chronic and sluggish inflammatory diseases occurs. Inflammatory periodontal disease and dental caries increase especially in the third trimester, and are most pronounced in complicated pregnancies. Changes in the cytokine profile in the mixed saliva of pregnant women reflect the state of local immunity and tissues of the oral cavity and indicate the participation of immunocompetent cells of the placenta and fetus in the response to the inflammatory process. Purpose: to characterize the effect of complex treatment of gingivitis with the use of a chewing phytosubstrate in women with edema caused by pregnancy on the level of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in the oral fluid. Materials and methods: the level of cytokines IL-1β, IL-6, TNF-α in the oral fluid was determined before and after complex treatment of gingivitis with the inclusion of a chewing phytosubstrate in women with edema caused by pregnancy. Conclusion: Inclusion in the complex treatment of gingivitis in women with edema caused by pregnancy, a chewable phytosubstrate containing 0.1 g of dry matter extract (oak bark, alder stems, birch buds, chamomile flowers, thyme grass) and 1.0 g beeswax, has a pronounced therapeutic effect, reducing the content of pro-inflammatory cytokines in the oral fluid, which reflects the suppression of the inflammatory process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.